Revvity Signals - Drug Discovery

Peptides and Peptidomimetics for Antimicrobial Drug Design

Biljana Mojsoska and Havard Jenssen

Abstract

This paper aims to provide an overview of traditional antimicrobial peptides, emphasizing structure-activity relationship studies. It begins by examining the key physiochemical properties that impact the antimicrobial and toxic characteristics of these peptides. The role of individual amino acids in the peptides' antibacterial properties is then discussed. The paper also delves into the mechanisms of action of various antimicrobials and the emergence of bacterial resistance to these peptides. Additionally, it explores ongoing research on novel design strategies and peptidomimetics, highlighting the significance of antimicrobial peptide studies in the development of future antibiotics.

Citation: Biljana Mojsoska and Håvard Jenssen (2015) Peptides and Peptidomimetics for Antimicrobial Drug Design Pharmaceuticals 2015, 8(3), 366-415; doi:10.3390/ph8030366

Received: 26 March 2015; Revised: 27 May 2015; Accepted: 17 June 2015; Published: 13 July 2015

Academic Editor: Guangshun Wang

Copyright: © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Concluding Remarks

There is increased evidence of emergence of bacteria resistant to conventional antibiotics illustrating the importance of research on antimicrobial drug development. Antimicrobial peptides and their synthetic derivatives hold vast potential in the development of novel antimicrobial drugs due to their (1) high biological activities; (2) low cost of production when compared with that of proteins and antibodies; (3) ease of structural modifications and stability improvements; (4) promising pharmacokinetic profiles; (5) degradation that leads to amino acids which are less toxic for the organism resulting in low immunogenicity and (6) good organ penetration.

The variety of structure-activity relationship studies for antimicrobial peptides demonstrate that the observed antibacterial activity is usually the outcome of multiple factors such as; secondary structures, amphipathicity, charge, length and hydrophobicity. The sequence composition together with the importance of specific residues and their contribution to the optimal therapeutic profiles of the peptides reveal important scaffolds for design of novel compounds to successfully combat and eliminate infectious diseases in the future.

Acknowledgments

BM holds a Ph.D. scholarship from The Danish Council for Independent Research (grant # 10-085287).

Conflicts of Interest : The authors declare no conflict of interest.